Frontiers in Oncology

SJR Rank #4,764H-index: 173SJR: 1.020Best quartile: Q2Open AccessAPC: US$3,801Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Frontiers Media SA

Country

Switzerland

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Cancer ResearchQ2
  • OncologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisRadiomics and Machine Learning in Medical ImagingCancer-related molecular mechanisms researchGlioma Diagnosis and TreatmentLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisLung Cancer Research StudiesRNA modifications and cancer

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0450090001350018000

Documents per Year

2022202502000400060008000

Detailed Information

ISSN

2234-943X

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

3.14

References per Document

45.62

Coverage

2011-2026

Scope

Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. The journal welcomes outstanding contributions in any domain of cancer research: from basic laboratory research to clinical investigation, from prevention to treatment, and from imaging studies to novel treatment strategies.

Metrics from SCImago Journal Rank 2025. View on SCImago